Doxycycline Export Market Intelligence: India's 408 Suppliers Shipping to 149 Countries — TransData Nexus 2026

Q: Who are the top doxycycline exporters from India?

The top doxycycline exporters from India are: 1. ZYDUS LIFESCIENCES LIMITED — $36.5M (30.8% market share); 2. USV PRIVATE LIMITED — $20.6M (17.4% market share); 3. ALEMBIC PHARMACEUTICALS LIMITED — $11.3M (9.5% market share); 4. MYLAN LABORATORIES LIMITED — $6.3M (5.3% market share); 5. AMNEAL PHARMACEUTICALS PRIVATE LIMITED — $5.3M (4.5% market share). Together they account for 67.5% of India's total doxycycline export value.

Q: What is the total export value of doxycycline from India?

The total export value of doxycycline from India is $118.6M USD, recorded across 5,999 shipment transactions from 408 active exporters to 149 destination countries. The average shipment value is $19.8K.

Q: Which countries import doxycycline from India?

India exports doxycycline to 149 countries worldwide. The top importing countries are: UNITED STATES (78.6% share, $93.2M), AUSTRALIA (4.0% share, $4.7M), ETHIOPIA (2.0% share, $2.4M), UNITED KINGDOM (1.9% share, $2.3M), BELGIUM (1.5% share, $1.8M). These five markets account for 88.0% of total export value.

Q: What is the HS code for doxycycline exports from India?

The primary HS code for doxycycline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of doxycycline exports from India?

The average unit price for doxycycline exports from India is $53.40 USD per unit, with prices ranging from $0.00 to $21698.56 depending on formulation, packaging, and order volume. The total market is valued at $118.6M across 5,999 shipments.

Q: Which ports handle doxycycline exports from India?

The primary ports for doxycycline exports from India are SAHAR AIR CARGO ACC (INBOM4) (27.2% of shipments), SAHAR AIR (20.3% of shipments), NHAVA SHEVA SEA (INNSA1) (5.6% of shipments), DELHI AIR CARGO ACC (INDEL4) (5.6% of shipments), Bombay Air (5.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of doxycycline?

India is one of the world's leading exporters of doxycycline due to its large base of 408 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports doxycycline to 149 countries, demonstrating 76% global market coverage.

Q: What certifications do Indian doxycycline exporters need?

Indian doxycycline exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import doxycycline from India?

There are 1,051 registered buyers importing doxycycline from India, spread across 149 countries. The repeat buyer rate is 41.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top doxycycline supplier from India?

ZYDUS LIFESCIENCES LIMITED is the leading doxycycline exporter from India with a market share of 30.8% and total export value of $36.5M across 78 shipments. The top 5 suppliers together control 67.5% of total export value.

Suresh Sormare

Doxycycline

India Pharmaceutical Trade Intelligence

$118.6M408 Suppliers149 CountriesHS 30049099

ExportsIndia → UNITED STATES78.6%India → AUSTRALIA4.0%

ImportsGERMANY → India$382.8K UNITED STATES → India$97.3K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Doxycycline Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Doxycycline to the World

Between 2022 and 2026, India exported $118.6M worth of doxycycline across 5,999 verified shipments to 149 countries — covering 76% of world markets in the Antibiotics segment. The largest destination is UNITED STATES (78.6%). ZYDUS LIFESCIENCES LIMITED leads with a 30.8% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Doxycycline export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Doxycycline export data snapshot — $118.6M · 408 exporters · 149 countriesTransData Nexus · Indian Customs Data

Top Doxycycline Exporters from India

408 active exporters · Ranked by export value

View all 408 →

Top Doxycycline Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ZYDUS LIFESCIENCES LIMITED	$36.5M	78	2	30.8%
2	USV PRIVATE LIMITED

Top Countries Importing Doxycycline from India

149 destination markets · Ranked by import value

All 149 countries →

Top Countries Importing Doxycycline from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$93.2M	78.6%
2	AUSTRALIA	$4.7M	4.0%
3	ETHIOPIA	$2.4M	2.0%
4	UNITED KINGDOM	$2.3M	1.9%
5	BELGIUM	$1.8M	1.5%
6	SOUTH AFRICA	$1.1M	0.9%
7	NETHERLANDS	$1.1M	0.9%
8	SRI LANKA	$1.1M	0.9%
9	VIETNAM	$917.4K	0.8%
10	UNITED ARAB EMIRATES	$799.5K	0.7%

UNITED STATES is India's largest doxycycline export destination, absorbing 78.6% of total exports worth $93.2M. The top 5 importing countries — UNITED STATES, AUSTRALIA, ETHIOPIA, UNITED KINGDOM, BELGIUM — together account for 88.0% of India's total doxycycline export value. The remaining 144 destination countries collectively receive the other 12.0%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Doxycycline to India?

12 origin countries · Total import value: $491.0K

India imports doxycycline from 12 countries with a combined import value of $491.0K. The largest supplier is GERMANY ($382.8K, 11 shipments), followed by UNITED STATES and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Doxycycline to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$382.8K	11	78.0%
2	UNITED STATES	$97.3K	59	19.8%
3	CHINA	$3.9K	5	0.8%
4	CANADA	$3.5K	16	0.7%
5	IRELAND	$1.7K	1	0.4%
6	SOUTH AFRICA	$890	4	0.2%
7	UNITED KINGDOM	$601	5	0.1%
8	SWITZERLAND	$138	3	0.0%
9	ISRAEL	$71	1	0.0%
10	DENMARK	$24	1	0.0%

Showing top 10 of 12 origin countries

GERMANY is the largest supplier of doxycycline to India, accounting for 78.0% of total import value. The top 5 origin countries — GERMANY, UNITED STATES, CHINA, CANADA, IRELAND — together supply 99.6% of India's doxycycline imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Doxycycline

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Doxycycline, a tetracycline-class antibiotic, is widely utilized in the United States for treating various bacterial infections. The FDA's Orange Book lists numerous approved Abbreviated New Drug Applications (ANDAs) for doxycycline, indicating a robust generic market presence. Notably, the FDA has not issued any import alerts specifically targeting doxycycline products from India, suggesting compliance with U.S. regulatory standards. Given that 78.6% of India's doxycycline exports are destined for the U.S., this underscores the critical importance of adhering to FDA regulations to maintain market access.

2EU & UK Regulatory Framework

In the European Union and the United Kingdom, doxycycline is subject to stringent regulatory oversight. The European Medicines Agency (EMA) and the UK's Medicines and Healthcare products Regulatory Agency (MHRA) require comprehensive marketing authorization applications, including evidence of Good Manufacturing Practice (GMP) compliance. Historical data, such as the EMA's referral procedures for doxycycline-containing products like Oracea in July 2008, highlight the necessity for thorough safety and efficacy evaluations. Manufacturers exporting to these regions must ensure their products meet all regulatory requirements to secure and maintain market authorization.

3WHO Essential Medicines & Global Standards

Doxycycline is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, underscoring its significance in global health. This inclusion reflects its efficacy and safety profile. Manufacturers are encouraged to adhere to international pharmacopoeia standards, such as those outlined in the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), to ensure product quality and facilitate global acceptance.

4India Regulatory Classification

In India, doxycycline is classified under Schedule H of the Drugs and Cosmetics Act, indicating it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) sets ceiling prices for essential medicines; however, the latest ceiling price for doxycycline should be verified through NPPA's official notifications. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the quality of pharmaceutical exports.

5Patent & Exclusivity Status

Doxycycline's primary patents have expired, leading to a competitive generic market. This patent expiration has facilitated the entry of multiple manufacturers, contributing to the availability and affordability of the drug globally.

6Recent Industry Developments

In May 2025, the WHO announced the development of guidelines for using doxycycline as post-exposure prophylaxis for sexually transmitted infections, reflecting its expanding therapeutic applications. Additionally, the 24th edition of the WHO Model List of Essential Medicines, published in September 2025, reaffirmed doxycycline's essential status, emphasizing its continued importance in treating bacterial infections. These developments highlight the evolving role of doxycycline in global health and the necessity for manufacturers to stay informed about regulatory and clinical advancements.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Doxycycline

Retail & reference prices across 9 markets vs. India FOB export price of $53.40/unit

Global Price Benchmark for Doxycycline across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Data not available	USD	No specific government or regulatory pricing information is available for Doxycycline 100mg tablets in the United States.
United Kingdom	Data not available	GBP	No specific government or regulatory pricing information is available for Doxycycline 100mg tablets in the United Kingdom.
Germany	Data not available	EUR	No specific government or regulatory pricing information is available for Doxycycline 100mg tablets in Germany.
Australia

Supply Chain Risk Assessment — Doxycycline

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry heavily relies on China for Key Starting Materials (KSMs) and intermediates essential for Active Pharmaceutical Ingredient (API) production, including those for doxycycline. This dependency exposes the supply chain to vulnerabilities stemming from China's environmental regulations and manufacturing practices. For instance, in July 2018, the closure of Chinese chemical plants due to environmental non-compliance led to significant supply disruptions and increased costs for Indian pharmaceutical manufacturers.

To mitigate such risks, the Indian government introduced the Production Linked Incentive (PLI) scheme in 2020, aiming to bolster domestic API manufacturing and reduce reliance on imports. This initiative seeks to enhance self-sufficiency and resilience within the pharmaceutical supply chain. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

The export market for doxycycline from India is notably concentrated, with the top five exporters—led by Zydus Lifesciences Limited holding a 30.8% share—accounting for 67.5% of total exports. Such concentration poses a risk, as disruptions affecting these key suppliers could significantly impact global supply. The PLI scheme, initiated in 2020, aims to diversify and strengthen the supplier base by incentivizing broader participation in API manufacturing. (pharmanow.live)

Access Complete Doxycycline Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 5,999 transactions across 149 markets.

Request Demo View Pricing

Frequently Asked Questions — Doxycycline Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top doxycycline exporters from India?

The leading doxycycline exporters from India are ZYDUS LIFESCIENCES LIMITED, USV PRIVATE LIMITED, ALEMBIC PHARMACEUTICALS LIMITED, and 12 others. ZYDUS LIFESCIENCES LIMITED leads with 30.8% market share ($36.5M). The top 5 suppliers together control 67.5% of total export value.

What is the total export value of doxycycline from India?

The total export value of doxycycline from India is $118.6M, recorded across 5,999 shipments from 408 active exporters to 149 countries. The average shipment value is $19.8K.

Which countries import doxycycline from India?

India exports doxycycline to 149 countries. The top importing countries are UNITED STATES (78.6%), AUSTRALIA (4.0%), ETHIOPIA (2.0%), UNITED KINGDOM (1.9%), BELGIUM (1.5%), which together account for 88.0% of total export value.

What is the HS code for doxycycline exports from India?

The primary HS code for doxycycline exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Doxycycline

Doxycycline

Top Doxycycline Exporters from India

Top Countries Importing Doxycycline from India

Who Supplies Doxycycline to India?

Quick Facts

Related Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Doxycycline

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Doxycycline

Supply Chain Risk Assessment — Doxycycline

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Doxycycline Trade Intelligence

Frequently Asked Questions — Doxycycline Exports from India

Who are the top doxycycline exporters from India?

What is the total export value of doxycycline from India?

Which countries import doxycycline from India?

What is the HS code for doxycycline exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of doxycycline exports from India?

Which ports handle doxycycline exports from India?

Why is India a leading exporter of doxycycline?

What certifications do Indian doxycycline exporters need?

How many buyers import doxycycline from India?

What is the market share of the top doxycycline exporter from India?

Analysis Methodology